Members of the Chebib lab and the clinical research team conduct a multidisciplinary review of participant cases. Dr. Chebib's dry lab focuses on understanding the natural history of ADPKD and accurate predictions and stratifications using comprehensive and novel biomarkers and other approaches.
Training opportunities
The Chebib PKD Research and Therapeutics Laboratory provides a highly collaborative and translational training environment to advance careers in nephrology, genetics and biomedical research.
Training philosophy
Our lab emphasizes rigorous science, translational impact and career development. Trainees benefit from a multidisciplinary ecosystem that integrates laboratory discovery, clinical investigation and industry collaboration. Our goal is to prepare the next generation of leaders in kidney research and therapeutics.
Postdoctoral fellows and research associates
Trainees engage in cutting-edge projects spanning molecular biology, translational therapeutics, imaging analytics and clinical research. Opportunities include exposure to drug development pipelines, gene therapy platforms and integrated multi-omics approaches.
Clinical research fellows
Physician-trainees participate in clinical trial design, patient phenotyping, biomarker development and translational research focused on ADPKD and inherited kidney diseases.
Students and visiting scholars
Our lab also offers mentored research experiences for medical students, graduate students and visiting scholars. The emphasis is on hypothesis-driven research and scientific communication.
Alumni
Our lab has a growing cohort of alumni.
Research fellows
- Marie Therese Bou Antoun, M.D., 2024-2026
- Ahmad Ghanem, M.D., 2023-2025
- Abdul Hamid Borghol, M.D., 2023-2025
- Fadi George Munairdjy Debeh, M.D., 2022-2025
- Stefan Paul, M.D., 2023-2024
Research trainees
- Hashem Sandouk, 2025-2026
- Levon Souvalian, M.D., 2025-2026
- Dana Hanna, M.D., 2024-2025
- Besher Shami, M.D., 2024-2025
- Nay Nader, M.D., 2023-2025
- Bassel AlKhatib, M.D., 2023-2024